| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | focal adhesion | 4.12e-04 | 431 | 66 | 7 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 4.85e-04 | 443 | 66 | 7 | GO:0030055 | |
| GeneOntologyCellularComponent | actin filament bundle | 5.31e-04 | 118 | 66 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | microtubule organizing center | NEDD9 MISP KIF3B PPP1R12A PDE4DIP ERCC6L2 SORBS1 HERC2 MTUS2 MARCKS | 5.79e-04 | 919 | 66 | 10 | GO:0005815 |
| Domain | GATA_ZN_FINGER_1 | 1.43e-03 | 16 | 66 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 1.43e-03 | 16 | 66 | 2 | PS50114 | |
| Domain | IQ | 2.03e-03 | 71 | 66 | 3 | PF00612 | |
| Pubmed | 1.99e-10 | 133 | 67 | 8 | 15144186 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.56e-08 | 231 | 67 | 8 | 16452087 | |
| Pubmed | IQSEC3 ZNF536 MAP7D1 KIF3B TENM3 PHF24 PDE4DIP SORBS1 R3HDM1 | 8.85e-08 | 407 | 67 | 9 | 12693553 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ANKRD36B NOLC1 MYLK ATRX CDK13 PPP1R12A PDE4DIP ADNP MAP2K5 HDGFL2 THRAP3 MARCKS | 1.53e-07 | 910 | 67 | 12 | 36736316 |
| Pubmed | 3.54e-07 | 347 | 67 | 8 | 17114649 | ||
| Pubmed | 7.03e-07 | 86 | 67 | 5 | 37253089 | ||
| Pubmed | NOLC1 IQSEC3 GAP43 SCN1A PCLO PDE4DIP SLC4A10 KCNAB1 SORBS1 THRAP3 CNOT2 MARCKS | 1.64e-06 | 1139 | 67 | 12 | 36417873 | |
| Pubmed | 1.69e-06 | 187 | 67 | 6 | 26460568 | ||
| Pubmed | 1.98e-06 | 591 | 67 | 9 | 15231748 | ||
| Pubmed | IQSEC3 MAP7D1 KIF3B TBC1D5 PPP1R12A PDE4DIP KCNAB1 SORBS1 HERC2 ADNP THRAP3 | 2.16e-06 | 963 | 67 | 11 | 28671696 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 2.66e-06 | 317 | 67 | 7 | 17620599 | |
| Pubmed | MYCN amplification and ATRX mutations are incompatible in neuroblastoma. | 3.66e-06 | 2 | 67 | 2 | 32060267 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 32794109 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 MAP7D1 TBC1D5 PPP1R12A GTSE1 MAP3K14 KDM3B NHS SORBS1 R3HDM1 | 5.69e-06 | 861 | 67 | 10 | 36931259 |
| Pubmed | 5.84e-06 | 506 | 67 | 8 | 30890647 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 6.24e-06 | 361 | 67 | 7 | 30344098 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 37460674 | ||
| Pubmed | How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma? | 1.10e-05 | 3 | 67 | 2 | 34439779 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 9344590 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10871285 | ||
| Pubmed | Substrate phosphorylation in the protein kinase Cgamma knockout mouse. | 1.10e-05 | 3 | 67 | 2 | 9890937 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 11087669 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 USP14 ATRX RPAP3 TBC1D5 PPP1R12A KDM3B ADNP HDGFL2 MARCKS | 1.15e-05 | 934 | 67 | 10 | 33916271 |
| Pubmed | MYCN PDE4DIP RNF20 KDM3B SECISBP2 SAMD14 FAM135A HDGFL2 THRAP3 MTUS2 | 2.18e-05 | 1006 | 67 | 10 | 15226823 | |
| Pubmed | Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo. | 2.19e-05 | 4 | 67 | 2 | 18524939 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 19017490 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 20855530 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 22544752 | ||
| Pubmed | NOLC1 USP14 ATRX CDK13 RNF20 KDM3B ADNP HDGFL2 THRAP3 CDCA7L | 2.34e-05 | 1014 | 67 | 10 | 32416067 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 MISP MAP7D1 TENT4B RPAP3 PPP1R12A ZFC3H1 ADNP THRAP3 MARCKS LGALS3BP | 2.64e-05 | 1257 | 67 | 11 | 36526897 |
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 3.37e-05 | 94 | 67 | 4 | 37468549 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 MISP MAP7D1 ATRX CDK13 RNF20 ZFC3H1 ADNP HDGFL2 THRAP3 CDCA7L | 3.44e-05 | 1294 | 67 | 11 | 30804502 |
| Pubmed | 3.52e-05 | 650 | 67 | 8 | 38777146 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 28867346 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYCN ZNF536 MAP7D1 PPP1R12A GTSE1 ADNP THRAP3 LGALS3BP FOXL1 | 3.82e-05 | 857 | 67 | 9 | 25609649 |
| Pubmed | 5.00e-05 | 104 | 67 | 4 | 10470851 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.13e-05 | 341 | 67 | 6 | 32971831 | |
| Pubmed | A genome-wide association study identifies susceptibility loci for Wilms tumor. | 5.46e-05 | 6 | 67 | 2 | 22544364 | |
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 11161817 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.79e-05 | 220 | 67 | 5 | 35785414 | |
| Pubmed | 7.94e-05 | 730 | 67 | 8 | 34857952 | ||
| Pubmed | 8.16e-05 | 371 | 67 | 6 | 15747579 | ||
| Pubmed | 8.17e-05 | 733 | 67 | 8 | 34672954 | ||
| Pubmed | IQSEC3 MISP MAP7D1 GAP43 PPP1R12A PCLO PDE4DIP SLC4A10 SORBS1 THRAP3 MTUS2 | 8.50e-05 | 1431 | 67 | 11 | 37142655 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 8.73e-05 | 120 | 67 | 4 | 31413325 | |
| Pubmed | NOLC1 AP1AR MAP7D1 MYLK ATRX CDK13 PPP1R12A PCLO ZFC3H1 HDGFL2 THRAP3 | 9.10e-05 | 1442 | 67 | 11 | 35575683 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.19e-04 | 774 | 67 | 8 | 15302935 | |
| Pubmed | 1.22e-04 | 777 | 67 | 8 | 35844135 | ||
| Pubmed | RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription. | 1.26e-04 | 50 | 67 | 3 | 30413534 | |
| Pubmed | ATRX NEMF PDE4DIP SORBS1 ZFC3H1 HERC2 R3HDM1 CNOT2 MTUS2 BRWD1 | 1.67e-04 | 1285 | 67 | 10 | 35914814 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.82e-04 | 430 | 67 | 6 | 35044719 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.96e-04 | 148 | 67 | 4 | 32538781 | |
| Pubmed | 1.99e-04 | 277 | 67 | 5 | 30745168 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.16e-04 | 444 | 67 | 6 | 34795231 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.20e-04 | 283 | 67 | 5 | 30585729 | |
| Pubmed | Image-based genome-wide siRNA screen identifies selective autophagy factors. | 2.58e-04 | 159 | 67 | 4 | 22020285 | |
| Pubmed | 2.58e-04 | 1103 | 67 | 9 | 34189442 | ||
| Pubmed | NOLC1 ZNF536 ZNF469 MAP7D1 PPP1R12A BICRAL PDZRN3 LGALS3BP BRWD1 | 2.81e-04 | 1116 | 67 | 9 | 31753913 | |
| Pubmed | 2.90e-04 | 469 | 67 | 6 | 27634302 | ||
| Pubmed | 3.28e-04 | 14 | 67 | 2 | 16452088 | ||
| Pubmed | 3.28e-04 | 14 | 67 | 2 | 15570572 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 MAP7D1 RPAP3 CDK13 NEMF RNF20 HDGFL2 THRAP3 MARCKS LGALS3BP | 3.61e-04 | 1415 | 67 | 10 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 3.82e-04 | 1425 | 67 | 10 | 30948266 | |
| Pubmed | NOLC1 ZNF536 MAP7D1 ATRX HERC2 R3HDM1 ADNP CNOT2 LGALS3BP FOXL1 | 3.90e-04 | 1429 | 67 | 10 | 35140242 | |
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 25416818 | ||
| Pubmed | 4.81e-04 | 723 | 67 | 7 | 34133714 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 4.85e-04 | 724 | 67 | 7 | 36232890 | |
| Pubmed | N-myc coordinates retinal growth with eye size during mouse development. | 5.48e-04 | 18 | 67 | 2 | 18198336 | |
| Pubmed | MAP7D1 TENT4B ATRX CDK13 PPP1R12A ZFC3H1 HERC2 HDGFL2 CNOT2 MARCKS | 5.61e-04 | 1497 | 67 | 10 | 31527615 | |
| Pubmed | 5.98e-04 | 538 | 67 | 6 | 28524877 | ||
| Pubmed | 6.45e-04 | 87 | 67 | 3 | 12465718 | ||
| Pubmed | 6.65e-04 | 549 | 67 | 6 | 38280479 | ||
| Pubmed | 6.67e-04 | 88 | 67 | 3 | 25144556 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.68e-04 | 361 | 67 | 5 | 26167880 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 6.84e-04 | 552 | 67 | 6 | 10737800 | |
| Pubmed | 7.50e-04 | 21 | 67 | 2 | 19686682 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 7.59e-04 | 92 | 67 | 3 | 15840729 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | NOLC1 MAP7D1 ATRX PPP1R12A SORBS1 HERC2 HDGFL2 THRAP3 LGALS3BP | 7.72e-04 | 1284 | 67 | 9 | 17353931 |
| Pubmed | 8.08e-04 | 94 | 67 | 3 | 16325481 | ||
| Pubmed | 8.24e-04 | 22 | 67 | 2 | 15084671 | ||
| Pubmed | 8.24e-04 | 22 | 67 | 2 | 14627618 | ||
| Pubmed | Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer. | 8.33e-04 | 95 | 67 | 3 | 35896951 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 8.42e-04 | 1038 | 67 | 8 | 26673895 | |
| Pubmed | 8.74e-04 | 220 | 67 | 4 | 24550385 | ||
| Pubmed | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. | 9.01e-04 | 23 | 67 | 2 | 25217961 | |
| Pubmed | 9.01e-04 | 23 | 67 | 2 | 12648490 | ||
| Pubmed | 9.04e-04 | 222 | 67 | 4 | 37071664 | ||
| Pubmed | PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. | 9.82e-04 | 24 | 67 | 2 | 24710276 | |
| Pubmed | 9.82e-04 | 24 | 67 | 2 | 24946904 | ||
| Pubmed | 1.07e-03 | 25 | 67 | 2 | 25848055 | ||
| Pubmed | 1.08e-03 | 104 | 67 | 3 | 9205841 | ||
| Pubmed | 1.11e-03 | 1084 | 67 | 8 | 11544199 | ||
| Pubmed | 1.12e-03 | 405 | 67 | 5 | 38187761 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.13e-03 | 608 | 67 | 6 | 36089195 | |
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 1.15e-03 | 26 | 67 | 2 | 34162889 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.20e-03 | 1367 | 67 | 9 | 32687490 | |
| Pubmed | 1.24e-03 | 27 | 67 | 2 | 18685082 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.26e-03 | 853 | 67 | 7 | 28718761 | |
| Pubmed | 1.30e-03 | 245 | 67 | 4 | 19521500 | ||
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 1.31e-03 | 111 | 67 | 3 | 22558309 | |
| Cytoband | 16q24 | 2.81e-04 | 17 | 67 | 2 | 16q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 1.06e-03 | 136 | 67 | 3 | chr16q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p13 | 2.17e-03 | 47 | 67 | 2 | chr3p13 | |
| Cytoband | 1p34.3 | 3.75e-03 | 62 | 67 | 2 | 1p34.3 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.68e-04 | 15 | 39 | 2 | 26 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ANKRD36B ATRX GAP43 SCN1A PCLO PDE4DIP SALL4 SORBS1 R3HDM1 SAMD14 MTUS2 BRWD1 | 2.10e-05 | 1106 | 67 | 12 | M39071 |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 2.30e-05 | 223 | 67 | 6 | M17621 | |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 3.63e-05 | 242 | 67 | 6 | M2128 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 4.38e-05 | 506 | 67 | 8 | M39067 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_200 | 4.80e-06 | 142 | 65 | 6 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | MAP7D1 ATRX RPAP3 TBC1D5 PPP1R12A RNF20 ADNP FAM135A CNOT2 BRWD1 | 7.77e-06 | 564 | 65 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | MYCN MAP7D1 ATRX GAP43 PPP1R12A PCLO PHF24 SALL4 ADNP FAM135A LGALS3BP BRWD1 | 4.00e-05 | 989 | 65 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 7.43e-05 | 73 | 65 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.91e-05 | 595 | 65 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NOLC1 MYCN ZNF536 ATRX GAP43 NEMF NHS SALL4 TNS4 R3HDM1 ADNP THRAP3 MARCKS BRWD1 | 1.16e-04 | 1468 | 65 | 14 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_100 | 1.34e-04 | 85 | 65 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#2_top-relative-expression-ranked_500 | 1.41e-04 | 86 | 65 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200 | 1.47e-04 | 164 | 65 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.47e-04 | 87 | 65 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | NOLC1 MYCN IQSEC3 PHF24 SALL4 FAM13B CDCA7L PDZRN3 MTUS2 LGALS3BP ADGRG6 | 1.55e-04 | 967 | 65 | 11 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | 1.95e-04 | 393 | 65 | 7 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_200 | 2.31e-04 | 39 | 65 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k4 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#2_top-relative-expression-ranked_200 | 2.49e-04 | 40 | 65 | 3 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 3.01e-04 | 422 | 65 | 7 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.46e-04 | 432 | 65 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.40e-08 | 188 | 67 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-07 | 177 | 67 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.09e-07 | 189 | 67 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.22e-07 | 190 | 67 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-07 | 194 | 67 | 6 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-07 | 194 | 67 | 6 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.92e-07 | 195 | 67 | 6 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-07 | 198 | 67 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.94e-06 | 157 | 67 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-06 | 164 | 67 | 5 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.32e-06 | 167 | 67 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.32e-06 | 167 | 67 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 6.14e-06 | 172 | 67 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.32e-06 | 173 | 67 | 5 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 6.32e-06 | 173 | 67 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.32e-06 | 173 | 67 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 7.45e-06 | 179 | 67 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.66e-06 | 180 | 67 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.87e-06 | 181 | 67 | 5 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.87e-06 | 181 | 67 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 8.30e-06 | 183 | 67 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.30e-06 | 183 | 67 | 5 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 183 | 67 | 5 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.30e-06 | 183 | 67 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-06 | 185 | 67 | 5 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-06 | 186 | 67 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.98e-06 | 186 | 67 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-06 | 188 | 67 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-06 | 188 | 67 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.45e-06 | 188 | 67 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.45e-06 | 188 | 67 | 5 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.70e-06 | 189 | 67 | 5 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.70e-06 | 189 | 67 | 5 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.95e-06 | 190 | 67 | 5 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 191 | 67 | 5 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.02e-05 | 191 | 67 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 191 | 67 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-05 | 192 | 67 | 5 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 67 | 5 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 194 | 67 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 195 | 67 | 5 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 195 | 67 | 5 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.13e-05 | 195 | 67 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 196 | 67 | 5 | 5159d8625d80c20eb28157b2603c8bde9d377a35 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-05 | 196 | 67 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 196 | 67 | 5 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 196 | 67 | 5 | 6b5b7dbcb2cce8a736e44145a01290905876a5e9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 196 | 67 | 5 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-05 | 197 | 67 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-05 | 197 | 67 | 5 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-05 | 197 | 67 | 5 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-05 | 197 | 67 | 5 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-05 | 197 | 67 | 5 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-05 | 197 | 67 | 5 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-05 | 197 | 67 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 198 | 67 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 198 | 67 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 1.21e-05 | 198 | 67 | 5 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 198 | 67 | 5 | cbb63b255bdc92a557c5db1f08f7766ed9346607 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 198 | 67 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 198 | 67 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 198 | 67 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 198 | 67 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 18-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 1.24e-05 | 199 | 67 | 5 | 9dd130c041beaa319727f9d22b3f45ba0da49487 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 199 | 67 | 5 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-05 | 199 | 67 | 5 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-05 | 200 | 67 | 5 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 200 | 67 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.27e-05 | 200 | 67 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.04e-05 | 127 | 67 | 4 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.08e-05 | 141 | 67 | 4 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.13e-05 | 152 | 67 | 4 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.92e-05 | 160 | 67 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.92e-05 | 160 | 67 | 4 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.02e-04 | 161 | 67 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.02e-04 | 161 | 67 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-04 | 161 | 67 | 4 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.04e-04 | 162 | 67 | 4 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.09e-04 | 164 | 67 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.12e-04 | 165 | 67 | 4 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 166 | 67 | 4 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 166 | 67 | 4 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 167 | 67 | 4 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 167 | 67 | 4 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Interneuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-04 | 63 | 67 | 3 | c10d344bf32a091deb79e1f128f7dd5e9f4abaa3 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 168 | 67 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 168 | 67 | 4 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 1.20e-04 | 168 | 67 | 4 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 168 | 67 | 4 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 168 | 67 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-04 | 171 | 67 | 4 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.28e-04 | 171 | 67 | 4 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 172 | 67 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-04 | 173 | 67 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-04 | 176 | 67 | 4 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 177 | 67 | 4 | 928118b0ed120ec01c7d753ce523ab609ac24e5f | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue | 1.49e-04 | 178 | 67 | 4 | c7895ba2e2e93b26da91faa2a3bf9d070dd4c3bd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.49e-04 | 178 | 67 | 4 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| Disease | age at initiation of corrective lens use | 1.37e-04 | 8 | 66 | 2 | EFO_0021781 | |
| Disease | Asthma, Occupational | 2.19e-04 | 10 | 66 | 2 | C0264423 | |
| Disease | ventricular septal defect (is_implicated_in) | 4.41e-04 | 14 | 66 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | Alpha ketoglutarate measurement | 5.79e-04 | 16 | 66 | 2 | EFO_0010457 | |
| Disease | Tourette syndrome, schizophrenia | 7.37e-04 | 18 | 66 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.11e-03 | 22 | 66 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.48e-03 | 100 | 66 | 3 | C0010606 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.20e-03 | 31 | 66 | 2 | C1335167 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSSSLSTFKDKNKND | 136 | Q9H2P0 | |
| LKPDSEDLSSQSSAS | 536 | Q5VTR2 | |
| SSKESSLSASPAQDK | 386 | Q14511 | |
| KKSSDNLGKSLSSSS | 1151 | Q86SQ4 | |
| PALKATSDEKDSFSN | 431 | Q8N2N9 | |
| NKKTGSNPTSASDDS | 241 | Q63HQ0 | |
| EAAAKAAKASNTSTP | 481 | Q14004 | |
| SSDPSADLKKASSSN | 811 | Q5JR59 | |
| ASSSNAAKSNLPKSG | 821 | Q5JR59 | |
| SSTDSDSSLRNLKPA | 361 | Q15032 | |
| LPEKSDKDSSSAYNT | 746 | Q9UPQ7 | |
| PGKAAAKASESSSSE | 116 | Q14978 | |
| PKKAKSSDSDSDSSS | 161 | Q14978 | |
| PASAKKGKAESSNSS | 506 | Q14978 | |
| ADPADSASGSSNKRK | 66 | Q8NDF8 | |
| KPSSLSTAEAKAATS | 446 | Q8IVT2 | |
| DASTASSSLSKSPEK | 2921 | Q8WXI7 | |
| DSLEAAAKSKNCSSP | 286 | Q15746 | |
| KAAIPSALDTNSSKS | 541 | Q08380 | |
| LASKEESSNSSDSKS | 796 | O60524 | |
| PESAAAAASDSLSAK | 976 | Q2M2H8 | |
| SAASNKISGASNSKP | 3361 | O95714 | |
| KKASENAKDSSLSPS | 36 | Q14722 | |
| DPEKLDSSSKALSFT | 536 | Q9NYF5 | |
| SSDVKSSCSSKPNLD | 931 | Q9P2D6 | |
| GLKKDSFSQESSPSS | 1391 | Q9Y6V0 | |
| VSDSLPSNSLKKSSA | 136 | Q13163 | |
| PLKTDSSASNSNSEL | 1191 | Q7LBC6 | |
| KPDKNSSSEQLFSSA | 156 | Q96GN5 | |
| LSSDKNSPNVSSKSF | 31 | Q6P9B6 | |
| SAKSGSEASASASKD | 606 | Q9UPP2 | |
| KAKSSEFASIPANSS | 331 | Q9NYZ3 | |
| KKAPSASDSDSKADS | 226 | Q7Z4V5 | |
| DSSAATSKAKPSLAS | 321 | Q9BWX5 | |
| LKLEESKATSSSNPS | 1981 | P46100 | |
| NSSNADPKSSLKGVS | 51 | Q6AI39 | |
| NSKFRPDTSSKSSDL | 2146 | Q9NSI6 | |
| AASAASSTSSPKAED | 126 | P29966 | |
| LSASTASELSPKSKA | 451 | Q3KQU3 | |
| SPKSSDKSKSFSIDS | 251 | Q12952 | |
| TAKNKAPDSSKASSS | 781 | Q5T890 | |
| KSPDAGSKAESSENS | 801 | Q9UJQ4 | |
| PNEKKLSESSTSLSS | 66 | A0A1B0GVS7 | |
| KSFASLESPESSKST | 841 | A6NGG8 | |
| DSLSLSDDSEKNPSK | 801 | Q99558 | |
| SDDSEKNPSKASQSS | 806 | Q99558 | |
| SFLEKSPSDKADTSS | 761 | Q6T4R5 | |
| ESATKASTDNSPSSK | 141 | P17677 | |
| SSEALSSDPSYNKEK | 341 | Q96T21 | |
| FSPKKSASQESTLSD | 266 | Q8IZD0 | |
| DSSPASSSSKSQDKT | 346 | Q9UPV7 | |
| SKEKLNESSSSSEGS | 1141 | P35498 | |
| SSYKDPTSSNDDSKS | 286 | Q9NZN8 | |
| LSSKASAESPSSESK | 441 | P48736 | |
| KSSSKDSRPSQAAGD | 181 | Q9Y2W1 | |
| KAKSLSPRNSDSEDS | 366 | P04198 | |
| SKKNSSQDDLFPTSD | 476 | Q9H6T3 | |
| SDSTDSPASCQKKSA | 566 | Q8IZW8 | |
| DASSFESTANKKSKA | 701 | O15066 | |
| ADNSKDKESSFPSKS | 1101 | Q6U841 | |
| LPSDKSQDATSSSAA | 141 | Q9BX66 | |
| AKDAKLSAPSSLAAS | 1466 | Q9P273 | |
| SSKDRSAASTPSKAL | 3651 | Q96JG9 | |
| TKPLSALSKDSSSDG | 1191 | O15090 | |
| PSSATKKDSFFSNIS | 556 | Q92609 | |
| TDSSSASAATPSKKK | 226 | P54578 | |
| KKQPDDDSAPSTSNS | 41 | Q9H8U3 | |
| SDQLKTSSSSPANSD | 796 | O60293 | |
| PKDNSDDKDLGSLSS | 281 | A6NMK8 | |
| SKPSSTSASQGAKAE | 1656 | Q5VU43 | |
| ASSPRLSSSLDNKEK | 471 | O14974 |